Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Robert

Showing results (231-240 of 274) with videos related to

Pageof 28
Sort By:
Marine Drugs|October 25, 2024
New Fusarochromanone Derivatives from the Marine Fungus <i>Fusarium equiseti</i> UBOCC-A-117302Giang Nam Pham, Béatrice Josselin, Arnaud Cousseau, et al.
Neurosurgical Review|June 2, 2025
Impact of acute hydrocephalus after aneurysmal SAH on longitudinal cognitive outcome- post-hoc analysis of the MoCA-DCI studyVincens Kälin, Svenja Maschke, Menno R Germans, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 KinasesViet Hung Dao, Isabelle Ourliac-Garnier, Cédric Logé, et al.
Kidney International Reports|September 18, 2024
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal KineticsMarion Sallee, Noémie Resseguier, Thomas Crepin, et al.
Bioorganic Chemistry|February 10, 2023
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studiesZaman Hasanvand, Tayebeh Oghabi Bakhshaiesh, Fariba Peytam, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Independent transcriptional reprogramming and apoptosis induction by cisplatinLorenzo Galluzzi, Ilio Vitale, Laura Senovilla, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK KinasesDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Blood|July 5, 2011
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemiaDominique Bluteau, Laure Gilles, Morgane Hilpert, et al.
Journal of the National Cancer Institute|April 6, 2006
Gene expression profiling of primary cutaneous melanoma and clinical outcomeVéronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, et al.
Clinical Kidney Journal|July 2, 2026
Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trialStanislas Bataille, Guillaume Seret, Frederic Lavainne, et al.
Pageof 28

Showing results (231-240 of 274) with videos related to

Sort By:
Pageof 28
Marine Drugs|October 25, 2024
New Fusarochromanone Derivatives from the Marine Fungus <i>Fusarium equiseti</i> UBOCC-A-117302Giang Nam Pham, Béatrice Josselin, Arnaud Cousseau, et al.
Neurosurgical Review|June 2, 2025
Impact of acute hydrocephalus after aneurysmal SAH on longitudinal cognitive outcome- post-hoc analysis of the MoCA-DCI studyVincens Kälin, Svenja Maschke, Menno R Germans, et al.
Molecules (Basel, Switzerland)|November 13, 2021
Dibenzofuran Derivatives Inspired from Cercosporamide as Dual Inhibitors of Pim and CLK1 KinasesViet Hung Dao, Isabelle Ourliac-Garnier, Cédric Logé, et al.
Kidney International Reports|September 18, 2024
Immunoadsorption and Plasma Exchange are Comparable in Anti-Neutrophil Cytoplasmic Antibodies or Anti-Glomerular Basement Membrane Removal KineticsMarion Sallee, Noémie Resseguier, Thomas Crepin, et al.
Bioorganic Chemistry|February 10, 2023
Imidazo[1,2-a]quinazolines as novel, potent EGFR-TK inhibitors: Design, synthesis, bioactivity evaluation, and in silico studiesZaman Hasanvand, Tayebeh Oghabi Bakhshaiesh, Fariba Peytam, et al.
Cell Cycle (Georgetown, Tex.)|August 25, 2012
Independent transcriptional reprogramming and apoptosis induction by cisplatinLorenzo Galluzzi, Ilio Vitale, Laura Senovilla, et al.
Molecules (Basel, Switzerland)|October 14, 2022
Structure Activity Relationship Studies around <i>DB18</i>, a Potent and Selective Inhibitor of CLK KinasesDabbugoddu Brahmaiah, Anagani Kanaka Durga Bhavani, Pasula Aparna, et al.
Blood|July 5, 2011
Down-regulation of the RUNX1-target gene NR4A3 contributes to hematopoiesis deregulation in familial platelet disorder/acute myelogenous leukemiaDominique Bluteau, Laure Gilles, Morgane Hilpert, et al.
Journal of the National Cancer Institute|April 6, 2006
Gene expression profiling of primary cutaneous melanoma and clinical outcomeVéronique Winnepenninckx, Vladimir Lazar, Stefan Michiels, et al.
Clinical Kidney Journal|July 2, 2026
Cholecalciferol and muscle strength in hemodialysis patients: results from the randomized VITADIAL trialStanislas Bataille, Guillaume Seret, Frederic Lavainne, et al.
Pageof 28